Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study

CONCLUSIONS: Tailored pharmaceutical care based on risk stratification, motivational interviewing, and new technologies has a positive influence to reduce the percentage of readmission in high risk HIV patients.PMID:34231351 | DOI:10.37201/req/025.2021

Source: Revista Espanola de Quimioterapia - July 7, 2021 Category: Drugs & Pharmacology Authors: M I Guzm án Ramos M Manzano Garcia M A Robustillo-Cort és A Guti érrez Pizarraya R Morillo-Verdugo Source Type: research